C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-08-23
DOI
10.3389/fpsyt.2018.00392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Syk and Src-targeted anti-inflammatory activity of aripiprazole, an atypical antipsychotic
- (2018) Sulgi Yoo et al. BIOCHEMICAL PHARMACOLOGY
- Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro
- (2018) Thiago Duarte et al. CYTOKINE
- High C-reactive protein levels are associated with depressive symptoms in schizophrenia
- (2018) M. Faugere et al. JOURNAL OF AFFECTIVE DISORDERS
- Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates
- (2018) Mariia Dorofeikova et al. PSYCHIATRY RESEARCH
- Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
- (2017) G. Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort
- (2017) G. Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set
- (2017) Guillaume Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- C-reactive protein and white blood cell levels in schizophrenia, bipolar disorders and depression - associations with mortality and psychiatric outcomes: a population-based study
- (2017) H.T. Horsdal et al. EUROPEAN PSYCHIATRY
- Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia
- (2017) R. Balõtšev et al. EUROPEAN PSYCHIATRY
- Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis
- (2017) Zhichao Wang et al. Oncotarget
- Clinical correlates of vitamin D deficiency in established psychosis
- (2016) J. Lally et al. BMC Psychiatry
- The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
- (2016) Erik Johnsen et al. BMC Psychiatry
- Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior
- (2016) R. Barzilay et al. EUROPEAN PSYCHIATRY
- Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set
- (2016) G. Fond et al. JOURNAL OF AFFECTIVE DISORDERS
- Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine
- (2016) Jari-Pekka Klemettilä et al. NORDIC JOURNAL OF PSYCHIATRY
- Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
- (2016) Ewa Bulzacka et al. SCHIZOPHRENIA BULLETIN
- nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives
- (2016) Vinay Parikh et al. SCHIZOPHRENIA RESEARCH
- Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers
- (2016) Rowena Handley et al. SCHIZOPHRENIA RESEARCH
- Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
- (2016) Narong Maneeton et al. Drug Design Development and Therapy
- Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
- (2016) Bram. P. Prins et al. PLOS MEDICINE
- So depression is an inflammatory disease, but where does the inflammation come from?
- (2016) Michael Berk et al. BMC Medicine
- Beyond the association.Toxoplasma gondiiin schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis
- (2015) A. L. Sutterland et al. ACTA PSYCHIATRICA SCANDINAVICA
- Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation
- (2015) Carlos A. Báez-Pagán et al. Journal of Neuroimmune Pharmacology
- C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
- (2015) B S Fernandes et al. MOLECULAR PSYCHIATRY
- Therapeutic effect of aripiprazole in chronic schizophrenia is accompanied by anti-inflammatory activity
- (2015) Jarosław Sobiś et al. Pharmacological Reports
- High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein
- (2015) Dao-min Zhu et al. PSYCHIATRY RESEARCH
- Personality and gene expression: Do individual differences exist in the leukocyte transcriptome?
- (2015) Kavita Vedhara et al. PSYCHONEUROENDOCRINOLOGY
- The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review
- (2015) G. Fond et al. SCHIZOPHRENIA BULLETIN
- Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
- (2015) Neil Mori et al. SCHIZOPHRENIA RESEARCH
- Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia
- (2015) Jean-Arthur Micoulaud-Franchi et al. SCHIZOPHRENIA RESEARCH
- Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
- (2015) Jamie Joseph et al. SCHIZOPHRENIA RESEARCH
- Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis
- (2015) Brendon Stubbs et al. SCHIZOPHRENIA RESEARCH
- Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
- (2015) O. Godin et al. SCHIZOPHRENIA RESEARCH
- Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome
- (2015) Irena Popovic et al. Srpski Arhiv za Celokupno Lekarstvo
- Quality of life is associated with chronic inflammation in schizophrenia: a cross-sectional study
- (2015) Faugere M. et al. Scientific Reports
- Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation
- (2015) Dorota Frydecka et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder
- (2014) Adam Wysokiński et al. NORDIC JOURNAL OF PSYCHIATRY
- Ecological studies: advantages and disadvantages
- (2014) P. Sedgwick BMJ-British Medical Journal
- Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life
- (2014) Golam M. Khandaker et al. JAMA Psychiatry
- Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review
- (2013) G. Fond et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Test of the Cognitive Self-Medication Hypothesis of Tobacco Smoking in Schizophrenia
- (2013) Britta Hahn et al. BIOLOGICAL PSYCHIATRY
- The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence
- (2013) Sandra Odebrecht Vargas Nunes et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells
- (2013) Verόnica Contreras-Shannon et al. PLoS One
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Elevated C-Reactive Protein Associated With Late- and Very-Late-Onset Schizophrenia in the General Population: A Prospective Study
- (2013) Marie Kim Wium-Andersen et al. SCHIZOPHRENIA BULLETIN
- Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
- (2013) Masahiro Nitta et al. SCHIZOPHRENIA BULLETIN
- Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
- (2013) Valérie Tourjman et al. SCHIZOPHRENIA RESEARCH
- Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
- (2013) Emily G. Severance et al. SCHIZOPHRENIA RESEARCH
- Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome
- (2012) C. Chassard et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses
- (2012) Brian J. Miller et al. BRAIN BEHAVIOR AND IMMUNITY
- Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls
- (2012) Katharina Drusch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
- (2012) Ingrid Dieset et al. SCHIZOPHRENIA RESEARCH
- C-reactive protein is elevated in schizophrenia
- (2012) Faith Dickerson et al. SCHIZOPHRENIA RESEARCH
- Log transformation: application and interpretation in biomedical research
- (2012) Changyong Feng et al. STATISTICS IN MEDICINE
- C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice
- (2011) A. Sicras-Mainar et al. EUROPEAN PSYCHIATRY
- Genome-wide association study identifies five new schizophrenia loci
- (2011) NATURE GENETICS
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
- (2011) Jonas Hannestad et al. NEUROPSYCHOPHARMACOLOGY
- C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
- (2011) Elizabeth B. Windgassen et al. POSTGRADUATE MEDICINE
- Inflammation in psychotic disorders: A population-based study
- (2011) Jaana Suvisaari et al. PSYCHIATRY RESEARCH
- Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia
- (2011) Faith Dickerson et al. SCHIZOPHRENIA RESEARCH
- Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
- (2009) Jonathan M. Meyer et al. BIOLOGICAL PSYCHIATRY
- Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications
- (2009) J.L.C. Conway MEDICAL HYPOTHESES
- Common variants on chromosome 6p22.1 are associated with schizophrenia
- (2009) Jianxin Shi et al. NATURE
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
- (2009) Shaun M. Purcell et al. NATURE
- Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients
- (2009) Abayomi O. Akanji et al. PSYCHIATRY RESEARCH
- Endogenous Retrovirus Type W GAG and Envelope Protein Antigenemia in Serum of Schizophrenic Patients
- (2008) Hervé Perron et al. BIOLOGICAL PSYCHIATRY
- Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration
- (2008) Nurith Amitai et al. PSYCHOPHARMACOLOGY
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now